🌟 Save the date ➡️ TTS- @QIAGEN jointly present: Cutting Edge Data on CMV Immunodiagnostics and Solid Organ Transplant, moderated by Camille Kotton.
Learn more 👉 https://t.co/rsQxAs1kY2
🗣️ @KottonNelson, Julián de la Torre Cisneros, Jose O. Reusing Jr., Martina Sester
🗓️Weds, 4 Dec @ 9:00 am (ET)
#transplanttwitter #medtwitter #organtransplantation #transplantation
AL Amyloidosis for Nephrologists - Treatment Standard:
▫️The renal involvement is seen in up to 70% of cases.
▫️The early recognition, appropriate staging, and a comprehensive understanding of treatment options are crucial to managing this disease.
🔗https://t.co/aEbqa4xjeV
Consider chronic graft pyelo in a kidney TXP pt with:
1) recurrent UTIs or repeat isolation of same bacteria in UCx
2) worsening CKD
3) chronic graft pain (can also be asymptomatic/pauci-symptomatic)
Underdiagnosed. Tx may improve graft outcomes. #TxID. https://t.co/pRT3cCAUa4
From the department of unintended consequences: A new focus on "waiting list mortality" metric from the United Network for Organ Sharing. For kidney transplant centers, this policy is not only illogical, but likely to hurt equity efforts. https://t.co/GRWWucYG2g
Efficacy/safety of SGLT2i in a large cohort of kidney transplant recipients.
All-cause mortality, DCGF, or Screat doubling was significantly lower in kidney transplant recipients w/ SGLT2i than in those without SGLT2i
#Flozins#flozinate
https://t.co/js2NpjRkvA
- Is breastfeeding contraindicated in kidney #transplant?
- What birth control should be used?
- Pregnancy outcomes in transplant vs dialysis
All this and more in the latest episode of Kidney Commute @nkf - CME credit #NephTwitter@kellyhbeers@silvishah
https://t.co/JrY7EehVKS
🆕Belatacept rescue conversion in kidney transplant recipients with vascular lesions (Banff cv score > 2): a retrospective cohort study
📖https://t.co/9N9hpGfEWP👈
Don't miss this live webinar on 4/11 about 2 recent T-cell mediated rejection papers @amjtransplant https://t.co/41ijIzqBLT Moderated by @mannonmom, @mmengelUofA, and Sindhu Chandran who will be joined by @helantera and Randhawa. @SandyFeng8
Covid (@UCSF) Chronicles, Day 741
A friend in his 70s who’s had a kidney transplant recently lamented, “I haven’t gone out in 2 years.” If decision making is complex for all of us, just imagine what it’s like for ~7 million immunocompromised Americans.
This 🧵is for them.(1/25)
Use of Organs from SARS-CoV-2 Infected Donors: Is It Safe? A Contemporary Review https://t.co/p3evtDDmjm new section on COVID in Current Transplantation Reports
Timely pieces on use of Paxlovid in transplant recipients:
https://t.co/NNRvm33ar2
@amjtransplant
and
https://t.co/DQolCyrzRW
@AJKDonline
@m_pereiramd @nyphospital@ColumbiaMed
(Apologies for missing twitter handles for most authors)
The AST just published a statement on Oral Antiviral Therapy for COVID-19 for Organ Transplant
Recipients.
https://t.co/G19xdMTB58
#TransplantTwitter@AST_IDCOP